- জেনেরিক নাম
- Rivaroxaban
- শক্তি
- 2.5 mg
- ডোজ ফর্ম
- Tablet
- প্রস্তুতকারক
- Delta Pharma Limited
৳ ৪.৯ ৳ ৫ ২% ছাড় প্রতি ইউনিট
দাম হালনাগাদ: ১৬ Nov ২০২৬
Rivadel 2.5 হলো Rivaroxaban-এর একটি ব্র্যান্ড, শক্তি ২.৫ mg, ট্যাবলেট আকারে। Rivaroxaban-এর অন্য ব্র্যান্ডগুলো এই পাতায় কম দাম থেকে সাজানো আছে, দাম তুলনা করতে পারবেন। এই ব্র্যান্ডের প্রস্তুতকারক Delta Pharma Limited। Rivadel 2.5-এর প্রতি ইউনিটের দাম ৫ টাকা। এই তথ্য শুধু জানার জন্য; ঔষধ সবসময় ডাক্তারের পরামর্শ অনুযায়ী খাবেন, মাত্রা বা ব্র্যান্ড নিয়ে প্রশ্ন থাকলে ফার্মাসিস্টকে জিজ্ঞেস করুন।
Rivaroxaban-এর ১৯টি ব্র্যান্ড বাংলাদেশে তালিকাভুক্ত। ইউনিট দামের হিসেবে Rivadel 2.5 এগুলোর মধ্যে সবচেয়ে কম দামিদের একটি।
Rivadel 2.5 2.5 mg tablet is a medicine made by Delta Pharma Limited. Anti-coagulants such as this are used in conditions where the risk of unwanted clots is a concern. Doctors prescribe it for adults after an acute coronary syndrome with raised cardiac biomarkers, alongside aspirin or aspirin with clopidogrel or ticlopidine. Ask your doctor or pharmacist if you are unsure why it has been prescribed for you.
It is an oral anticoagulant, sometimes called a blood thinner. Rivadel 2.5 is used as an anticoagulant. It is not a painkiller or a general tonic and should not be used for other purposes. Ask your doctor what Rivadel 2.5 is being prescribed for in your case.
Swallow the tablet as advised, and keep to the schedule your doctor sets. Swallow the tablet with water. Rivadel 2.5 is taken by mouth. Do not take more than prescribed. Tell your doctor about all other medicines you take. Follow the doctor's instructions exactly and do not change the dose yourself.
Seek medical help for unusual or persistent bleeding, and ask your doctor about any other effects you notice. Your doctor or pharmacist can explain what warning signs to watch for. In people with nonvalvular atrial fibrillation, stopping the medicine has been linked to an increased risk of stroke. Tell your doctor promptly about any unusual or prolonged bleeding. Tell your doctor if any side effect bothers you or does not go away.
Pregnant or breastfeeding women should speak to their doctor first. It must not be used if you are allergic to Rivaroxaban or have active pathological bleeding. The risk of bleeding is higher in people with bleeding disorders, uncontrolled severe high blood pressure, certain gastrointestinal diseases, vascular retinopathy, bronchiectasis or a history of pulmonary bleeding, so these should be discussed with the doctor first. Ask your doctor first if any of these apply to you.
It is an oral anticoagulant, sometimes called a blood thinner. Rivadel 2.5 is used as an anticoagulant.
Swallow the tablet as advised, and keep to the schedule your doctor sets. Swallow the tablet with water.
Seek medical help for unusual or persistent bleeding, and ask your doctor about any other effects you notice. Your doctor or pharmacist can explain what warning signs to watch for.
Pregnant or breastfeeding women should speak to their doctor first. It must not be used if you are allergic to Rivaroxaban or have active pathological bleeding.
৳ ৪.৯ ৳ ৫ ২% ছাড় প্রতি ইউনিট
দাম হালনাগাদ: ১৬ Nov ২০২৬
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Rivaroxaban 2.5 mg:এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Rivaroxaban is a highly selective direct factor Xa inhibitor. Inhibition of factor Xa interrupts the intrinsic and extrinsic pathway of the blood coagulation cascade, inhibits thrombin formation. Rivaroxaban does not inhibit thrombin (activated factor II) and no effects on platelets have been demonstrated.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Rivaroxaban 2.5 mg:এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Concomitant use with drugs that are combined P-gp and CYP3A4 inhibitors (ketoconazole, ritonavir, clarithromycin, erythromycin, fluconazole, diltiazem, verapamil, dronedarone) increases in Rivaroxaban exposure and pharmacodynamic effects (i.e., factor Xa inhibition and PT prolongation), that’s why should be avoided. Co-administration of Rivaroxaban with a combined P-gp and strong CYP3A4 inducer (e.g., rifampicin, phenytoin, carbamazepine) decreases the efficacy of Rivaroxaban and also should be avoided. The concomitant use of other drugs like anti-platelet agents, heparin, fibrinolytic therapy, NSAIDs may cause an increased risk of bleeding.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
It is contraindicated in patients with known hypersensitivity of Rivaroxaban or any of the excipients of the product. It is also contraindicated in patients with active pathological bleeding.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
The most common side effects of Rivaroxaban have increased chance of bleeding, spinal or epidural hematoma and increased risk of stroke after discontinuation in nonvalvular atrial fibrillation.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Rivaroxaban is a pregnancy category C drug. There are no adequate or well-controlled studies of Rivaroxaban in pregnant women, and dosing for pregnant women has not been established. It is not known if Rivaroxaban is excreted in human milk. The safety and efficacy of Rivaroxaban has not been established in breastfeeding women.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Early discontinuation of Rivaroxaban, in the absence of adequate alternative anticoagulation increases the risk of thrombotic events. Rivaroxaban increases the risk of bleeding that can be fatal in presence of following risk factors- bleeding disorders, uncontrolled severe arterial hypertension, gastrointestinal disease (e.g., inflammatory bowel disease, oesophagitis, gastritis and gastroesophageal reflux disease), vascular retinopathy, bronchiectasis, history of pulmonary bleeding. Signs or symptoms of neurological impairment should be monitored in case of neuraxial anesthesia (spinal/epidural anesthesia) or spinal puncture as epidural or spinal hematoma can occur. Rivaroxaban is not recommended in patients with pulmonary embolism who present with hemodynamic instability or who may receive thrombolysis or pulmonary embolectomy.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Overdose of Rivaroxaban may lead to hemorrhage. Rivaroxaban systemic exposure is not further increased at single doses >50 mg due to limited absorption. A specific antidote for Rivaroxaban is not available. The use of activated charcoal to reduce absorption in case of Rivaroxaban overdose may be considered. Partial reversal of laboratory anticoagulation parameters may be achieved with use of plasma products.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Store in a cool (below 30°C) & dry place protected from light. Keep away from the reach of children.একই জেনেরিকের অন্য ব্র্যান্ড, কম দাম আগে।
ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।